Cargando…

Proficiency testing for SARS-CoV-2 whole genome sequencing

Extensive studies and analyses into the molecular features of severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) have enhanced the surveillance and investigation of its clusters and transmission worldwide. The whole genome sequencing (WGS) approach is crucial in identifying the sou...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Katherine A., Horan, Kristy, Gonçalves da Silva, Anders, Kaufer, Alexa, Theis, Torsten, Ballard, Susan A., Rawlinson, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Pathologists of Australasia. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239710/
https://www.ncbi.nlm.nih.gov/pubmed/35778290
http://dx.doi.org/10.1016/j.pathol.2022.04.002
_version_ 1784737367530143744
author Lau, Katherine A.
Horan, Kristy
Gonçalves da Silva, Anders
Kaufer, Alexa
Theis, Torsten
Ballard, Susan A.
Rawlinson, William D.
author_facet Lau, Katherine A.
Horan, Kristy
Gonçalves da Silva, Anders
Kaufer, Alexa
Theis, Torsten
Ballard, Susan A.
Rawlinson, William D.
author_sort Lau, Katherine A.
collection PubMed
description Extensive studies and analyses into the molecular features of severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) have enhanced the surveillance and investigation of its clusters and transmission worldwide. The whole genome sequencing (WGS) approach is crucial in identifying the source of infection and transmission routes by monitoring the emergence of variants over time and through communities. Varying SARS-CoV-2 genomics capacity and capability levels have been established in public health laboratories across different Australian states and territories. Therefore, laboratories performing SARS-CoV-2 WGS for public health purposes are recommended to participate in an external proficiency testing program (PTP). This study describes the development of a SARS-CoV-2 WGS PTP. The PTP assessed the performance of laboratories while providing valuable insight into the current state of SARS-CoV-2 genomics in public health across Australia. Part 1 of the PTP contained eight simulated SARS-CoV-2 positive and negative specimens to assess laboratories' wet and dry laboratory capacity. Part 2 involved the analysis of a genomic dataset that consisted of a multi-FASTA file of 70 consensus genomes of SARS-CoV-2. Participating laboratories were required to (1) submit raw data for independent bioinformatics analysis, (2) analyse the data with their processes, and (3) answer relevant questions about the data. The performance of the laboratories was commendable, despite some variation in the reported results due to the different sequencing and bioinformatics approaches used by laboratories. The overall outcome is positive and demonstrates the critical role of the PTP in supporting the implementation and validation of SARS-CoV-2 WGS processes. The data derived from this PTP will contribute to the development of SARS-CoV-2 bioinformatic quality control (QC) and performance benchmarking for accreditation.
format Online
Article
Text
id pubmed-9239710
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Royal College of Pathologists of Australasia. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92397102022-06-29 Proficiency testing for SARS-CoV-2 whole genome sequencing Lau, Katherine A. Horan, Kristy Gonçalves da Silva, Anders Kaufer, Alexa Theis, Torsten Ballard, Susan A. Rawlinson, William D. Pathology Virology Extensive studies and analyses into the molecular features of severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) have enhanced the surveillance and investigation of its clusters and transmission worldwide. The whole genome sequencing (WGS) approach is crucial in identifying the source of infection and transmission routes by monitoring the emergence of variants over time and through communities. Varying SARS-CoV-2 genomics capacity and capability levels have been established in public health laboratories across different Australian states and territories. Therefore, laboratories performing SARS-CoV-2 WGS for public health purposes are recommended to participate in an external proficiency testing program (PTP). This study describes the development of a SARS-CoV-2 WGS PTP. The PTP assessed the performance of laboratories while providing valuable insight into the current state of SARS-CoV-2 genomics in public health across Australia. Part 1 of the PTP contained eight simulated SARS-CoV-2 positive and negative specimens to assess laboratories' wet and dry laboratory capacity. Part 2 involved the analysis of a genomic dataset that consisted of a multi-FASTA file of 70 consensus genomes of SARS-CoV-2. Participating laboratories were required to (1) submit raw data for independent bioinformatics analysis, (2) analyse the data with their processes, and (3) answer relevant questions about the data. The performance of the laboratories was commendable, despite some variation in the reported results due to the different sequencing and bioinformatics approaches used by laboratories. The overall outcome is positive and demonstrates the critical role of the PTP in supporting the implementation and validation of SARS-CoV-2 WGS processes. The data derived from this PTP will contribute to the development of SARS-CoV-2 bioinformatic quality control (QC) and performance benchmarking for accreditation. Royal College of Pathologists of Australasia. Published by Elsevier B.V. 2022-08 2022-06-29 /pmc/articles/PMC9239710/ /pubmed/35778290 http://dx.doi.org/10.1016/j.pathol.2022.04.002 Text en © 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Virology
Lau, Katherine A.
Horan, Kristy
Gonçalves da Silva, Anders
Kaufer, Alexa
Theis, Torsten
Ballard, Susan A.
Rawlinson, William D.
Proficiency testing for SARS-CoV-2 whole genome sequencing
title Proficiency testing for SARS-CoV-2 whole genome sequencing
title_full Proficiency testing for SARS-CoV-2 whole genome sequencing
title_fullStr Proficiency testing for SARS-CoV-2 whole genome sequencing
title_full_unstemmed Proficiency testing for SARS-CoV-2 whole genome sequencing
title_short Proficiency testing for SARS-CoV-2 whole genome sequencing
title_sort proficiency testing for sars-cov-2 whole genome sequencing
topic Virology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239710/
https://www.ncbi.nlm.nih.gov/pubmed/35778290
http://dx.doi.org/10.1016/j.pathol.2022.04.002
work_keys_str_mv AT laukatherinea proficiencytestingforsarscov2wholegenomesequencing
AT horankristy proficiencytestingforsarscov2wholegenomesequencing
AT goncalvesdasilvaanders proficiencytestingforsarscov2wholegenomesequencing
AT kauferalexa proficiencytestingforsarscov2wholegenomesequencing
AT theistorsten proficiencytestingforsarscov2wholegenomesequencing
AT ballardsusana proficiencytestingforsarscov2wholegenomesequencing
AT rawlinsonwilliamd proficiencytestingforsarscov2wholegenomesequencing